Trityl Irbesartan CAS 138402-10-5 Purity >98.0% (HPLC) Irbesartan Intermediate Factory
Ruifu Chemical Supply Irbesartan Intermediates:
Irbesartan CAS 138402-11-6
Cyano-Irbesartan CAS 138401-24-8
Trityl Irbesartan CAS 138402-10-5
TTBB CAS 124750-51-2
Irbesartan Side Chain Hydrochloride CAS 151257-01-1
Jeneng Kimia | Tritil Irbesartan |
sinonim | Triphenyl Irbesartan;Irbesartan N1-Trityl Impurity;2-Butil-3-((2'-(2-tritil-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)metil)-1,3-diazaspiro[4.4]non -1-en-4-siji;2-Butil-3-[[4-[2-(2-tritil-tetrazol-5-yl)fenil]fenil]metil]-1,3-diazaspiro[4.4]non-1-en-4-siji |
Nomer CAS | 138402-10-5 |
Nomer CAT | RF-PI1893 |
Status Simpenan | Ing Simpenan, Skala Produksi Nganti Ton |
Formula Molekul | C44H42N6O |
Bobot Molekul | 670.84 |
Kapadhetan | 1,20±0,10 g/cm3 |
Titik didih | 834,6±75,0 ℃ ing 760 mmHg |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Bubuk Putih nganti Putih |
Kemurnian / Metode Analisis | > 98,0% (HPLC) |
Mundhut ing Pangatusan | <1.00% |
Sisa ing Ignition | <0,50% |
Impurity Tunggal | <1.00% |
Total Impurities | <2.00% |
Logam abot | <20 ppm |
Spektrum Infra Merah | Conforms kanggo Struktur |
Test Standar | Standar Perusahaan |
Panggunaan | Intermediate / Impurity of Irbesartan (CAS: 138402-11-6) |
Paket: Botol, tas Aluminium foil, 25kg / Karton Drum, utawa miturut kabutuhan pelanggan
Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan
Trityl Irbesartan (CAS: 138402-10-5) minangka penengah utawa najis saka Irbesartan (CAS: 138402-11-6).Irbesartan minangka blocker reseptor angiotensin II (ARB) sing dituduhake kanggo: Perawatan hipertensi, kanggo nyuda tekanan getih.Ngurangi tekanan getih nyuda risiko kedadeyan kardiovaskular sing fatal lan nonfatal, utamane stroke lan infark miokard.Perawatan nefropati diabetik ing pasien hipertensi kanthi diabetes tipe 2, bun serum munggah pangkat, lan proteinuria.Irbesartan dikembangake dening Sanofi Research (saiki dadi bagean saka Sanofi-Aventis).Iki dipasarake bebarengan dening Sanofi-Aventis lan Bristol-Myers Squibb kanthi jeneng dagang Aprovel, Karvea, lan Avapro.